Sign in
4

Changes in Ownership

Protagonist Therapeutics, Inc Filed Acc 0001209191-21-010401

Director sold 8,400 shares at an average $25.30 ($212,555)

  • Director acquired 8,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Noonberg Sarah B. · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-10 Grant or award : show line 1 in the form +4,700 $6.98 $32,806 4,700 D
2021-02-10 Sale : show line 2 in the form −4,300 $25.42 $109,306 400 D
2021-02-10 Sale : show line 3 in the form −400 $26.04 $10,416 0 D
2021-02-11 Grant or award : show line 4 in the form +3,700 $6.98 $25,826 3,700 D
2021-02-11 Sale : show line 5 in the form −3,700 $25.09 $92,833 0 D
Open-market sales · 8,400 sh · avg $25.30 · $212,555

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-10 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −4,700 7,300 D
2021-02-11 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −3,700 3,600 D
Loading xslF345X03/doc4.xml…